Please do not leave this page until complete. This can take a few moments.
Marlborough biotech company Phio Pharmaceuticals Corp. announced the pricing of its public stock offering of 10 million shares of its common stock at 10 cents per share for gross proceeds of $1 million.
The offering is expected to close Tuesday subject to the satisfaction of customary closing conditions.
Phio is developing the next generation of immuno-oncology therapeutics to treat cancer. Phio said it intends to use the proceeds to fund the development of its immuno-oncology programs, for other research and development activities, and working capital needs.
The offering comes on the heels of Phio’s stock which tumbled last week after a third quarter earnings report showing increased losses.
The company reported net losses for the quarter of $2.1 million, or 8 cents per share, compared to $1.5 million, or 34 cents per share, for the third quarter of 2018.
These losses were a result of additional operating expenses rising to $1 million for research and development and $1.1 million for general and administrative expenses, compared to $800,000
New York City financial institution H.C. Wainwright & Co. is acting as exclusive placement agent for the offering.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments